IGC Pharma (IGC) Net Shares Issued and Repurchased (2011 - 2018)

IGC Pharma (IGC) has reported Net Shares Issued and Repurchased for 8 consecutive years, with $4.2 million the latest figure, recorded in Q2 2018.

• On a quarterly basis, Net Shares Issued and Repurchased rose 2021.17% year-over-year to $4.2 million in Q2 2018; TTM through Jun 2018 was $4.2 million, a 2021.17% increase from a year earlier, with the FY2018 full-year figure at $490000.0, up 206.25% from the prior year.
• Net Shares Issued and Repurchased was $4.2 million for Q2 2018 at IGC Pharma, up from $490000.0 in the prior quarter.
• Over five years, Net Shares Issued and Repurchased peaked at $4.2 million in Q2 2018 and troughed at $130045.0 in Q1 2016.
• A 5-year average of $956421.0 and a median of $269345.0 in 2014 frame the typical range for Net Shares Issued and Repurchased.
• Across the five-year window, Net Shares Issued and Repurchased slumped 51.72% in 2016 and surged 2021.17% in 2018, its largest moves.
• Over 5 years, Net Shares Issued and Repurchased stood at $269345.0 in 2014, then surged by 416.7% to $1.4 million in 2015, then slumped by 90.66% to $130045.0 in 2016, then jumped by 1018.84% to $1.5 million in 2017, then soared by 191.57% to $4.2 million in 2018.
• The last three Net Shares Issued and Repurchased figures came in at $4.2 million (Q2 2018), $490000.0 (Q1 2018), and $1.5 million (Q4 2017), per Business Quant data.